ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2019

Jan 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2019-01-01

Reporting Person: Li Zhen (Snr. VP, Chem and Non-Clin Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-01	Common Stock	A	75000	$0.00	Acquired	242200	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.